StockData
DataMeds AI, Inc. logo

DataMeds AI, Inc. (MEDS) stock

MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.74+0.10 (+15.41%)

Close on Nov 18, 2026Market cap $2.26MP/E –Yield –

DataMeds AI price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

DataMeds AI's price to sales ratio was 0.3× on Nov 11, 2026, against 1.6× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−0.7
2025Dec 31, 20251.0×–

More DataMeds AI figures

See a number that looks wrong?